scispace - formally typeset
D

David A. Jackson

Researcher at King's College London

Publications -  1166
Citations -  76015

David A. Jackson is an academic researcher from King's College London. The author has contributed to research in topics: Optical fiber & Interferometry. The author has an hindex of 136, co-authored 1095 publications receiving 68352 citations. Previous affiliations of David A. Jackson include University of California, Berkeley & University of Alberta.

Papers
More filters
Journal ArticleDOI

Interferometric chromatic dispersion measurements on short lengths of monomode optical fiber

TL;DR: In this paper, the first-order chromatic dispersion coefficient (D( lambda )) resolution of 0.07 ps was achieved for a 1-m length of fiber, equivalent to 0.06% resolution in the measurement technique.
Journal ArticleDOI

Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1) *

TL;DR: It is shown that stabilin-1 is almost entirely intracellular in lymph node high endothelial venules, lymphatic sinus endothelium, and cultured endothelial cells but that a finite population of cells cycles rapidly between the plasma membrane and EEA-1+ve (early endosome antigen 1) early endosomes.
Journal ArticleDOI

Lymphatics and bone.

TL;DR: Results indicate that the lymphatic circulation is unlikely to play a role in bone fluid transport in normal bone and that lymphatic vessels are absent from most primary and secondary tumors confined to bone, suggesting that lymphangiogenesis is not involved in the disease progression of most primary bone tumors and that carcinomatous metastasis to bone does not occur via lymphatics.
Journal ArticleDOI

Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization

TL;DR: LYVE-1 is revealed as a low affinity receptor tuned to discriminate between different HA configurations through avidity and establish a new mechanistic basis for the functions ascribed to LYve-1 in matrix HA binding and leukocyte trafficking in vivo.